Navigation Links
Prodesse gets new funding; improves flu assay

Waukesha, Wis. -- Prodesse, Inc. announced Monday that it has received additional business investment and that it has completed a major process improvement to its ProFlu-1 assay.

The company reported that a group of its core investors, plus three new accredited individuals, have provided an additional $850,000 in funding. The offering is comp......

Full article >>> t prestigious US labs."



......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/22/05


Related biology technology :

1. Prodesse begins clinical trials for flu virus detection
2. Prodesse joins forces with Invitrogen
3. Prodesse enters patent agreement with Roche
4. Entrepreneurial Profile: Kelly Henrickson, founder of Prodesse, Inc.
5. Addition of imidazole during binding improves purity of histidine-tagged proteins
6. Wisconsins entrepreneurial climate improves
7. Harvard advance improves stem cell research; not a medical revolution
8. Dane County improves law enforcement and community services
9. Teramedica Signs Deal With Mayo Clinic - Digital Imaging solution improves healthcare
10. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
11. LiquiChip Kits for bead-based cytokine and kinase assays
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
Breaking Biology News(10 mins):